ATLANTA, July 15 /PRNewswire/ -- IMS HEALTH (NYSE: RX) has won a major
contract with Roche in Brazil to implement an advanced sales force automation
system through its Sales Technologies/Walsh unit, the leading global provider
of sales force automation products and services to the pharmaceutical
industry.
The Roche contract, which was won against a major international
competitor, calls for the deployment of Premiere(SM), one of Sales
Technologies/Walsh's leading products. When implemented in September, the
system will support 500 sales force users.
"This agreement makes us the unchallenged leader in the large Brazilian
market," said Ronald Brown, chief executive officer, Sales Technologies/Walsh.
"It signals our continued expansion throughout the Latin American region."
Sales Technologies/Walsh has additional contracts in Brazil with Zeneca,
Whitehall and Wyeth. The unit recently opened an office in Sao Paolo to
provide local customer support and serve as a springboard for further Latin
American expansion.
"Brazil is the sixth largest pharmaceutical market in the world, yet most
of the pharmaceutical companies there are currently paper-based," said Robert
Mander, president and chief operating officer, Sales Technologies/Walsh. "We
see tremendous growth potential for our strategic technologies in Brazil."
Sales Technologies/Walsh is the leading global provider of sales force
automation products and services to the pharmaceutical industry. More than
35,000 pharmaceutical executives worldwide depend on Sales Technologies/Walsh
to make business decisions each day. Services include sales force automation
systems, strategic sales and marketing information solutions, and the
provision of client-critical databases. Additional information is available
at http://www.salestech.com.
Sales Technologies/Walsh is a division of IMS HEALTH (NYSE: RX), the
world's leading provider of information solutions to the pharmaceutical and
healthcare industries. With more than $1 billion in 1997 revenue, IMS HEALTH
operates in over 90 countries. IMS HEALTH is the largest pharmaceutical
manufacturer information partner, with over 40 years' experience in the
industry. Key products and services integral to customer day-to-day
operations include: market research for prescription and over-the-counter
pharmaceutical products; sales management information to optimize sales force
productivity; technology enabled selling solutions for sales and marketing
decision-making; and technology systems and information services that support
managed care organizations. Additional information is available at
http://imshealth.com.
SOURCE IMS HEALTH
 back to top
Company News On-Call: http://www.prnewswire.com or
fax, 800-758-5804, ext. 115785
CONTACT:
Mary Margaret Ray of IMS HEALTH, 404-841-4148
|
